Dietitians Australia and Exercise and Sports Science Australia have made a joint submission to the Pharmaceutical Benefits Advisory Committee (PBAC), recommending the PBAC:

• Advise the government that PBS-subsidised GLP-1 treatments be accompanied by funded, voluntary referral pathways to Accredited Exercise Physiologists and Accredited Practising Dietitians during treatment and following dose reduction or cessation.
• Refer the need for complementary Medicare funding to the Australian Government, including up to 12 funded APD and AEP services in the first year of GLP-1 treatment, with ongoing access in later years during treatment and following dose reduction or cessation
• Recommend that post-listing evaluation by the government includes nutrition status, muscle strength and physical function alongside weight loss and cardiovascular outcomes.

Read the full submission.